Decompensation of Cirrhosis and Iron Metabolism (DeCiFer)

Rennes University Hospital

Status: Unknown

Conditions: Cirrhosis

Treatments: Biological: blood sampling

Study type: Observational

Funder types: Other

Identifiers

NCT04807023

2020-A02454-35 (Other Identifier)

35RC20_8895_DeCiFer

Details and patient eligibility

About

Iron is a crucial metal whose metabolism is tightly regulated. Iron deficiency or iron overload are both deleterious at the cellular, organic and systemic levels. In line with the major role of the liver in iron homeostasis, links between iron metabolism and acute on chronic liver failure have been highlighted. Nevertheless, due to the difficulty of accurately assessing iron metabolism in this situation, therapeutic intervention on iron metabolism in this setting is currently not codified.

A better understanding of these mechanisms is therefore essential, in particular by characterizing the impact of exposure to non-transferrin-bound iron in acute on chronic liver failure on short-term mortality.

Overall, a better understanding of the physiopathological mechanisms of iron should allow to optimize the martial balance in this condition and also improve therapeutic approaches.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥ 18 years old.
• Diagnosis of cirrhosis, previously known or not, of any etiology, histologically proven or not.
• Hospitalization for acute on chronic liver failure:
• Ascites decompensation.
• Or spontaneous infection of the ascites fluid (defined as PNN > 250/mm3 of ascites).
• Or digestive hemorrhage related to portal hypertension (digestive fibroscopy showing active bleeding or stigmas of recent bleeding from esophageal and/or gastric varices).
• Or hepatic encephalopathy (clinically defined +/- increase in ammonia and/or by electroencephalogram and classified in stages according to West-Haven).
• Or hepato-renal syndrome (HRS-AKI criteria, EASL 2018).
• Or bacterial infection (defined by a bacteremia identified by at least one blood culture and/or an infectious site authenticated on imaging).
• Or Acute Alcoholic Hepatitis (histologically proven or not).
• Non-opposition of the patient, relative or legal representative.

Exclusion criteria

• Treatment with oral or intravenous iron in the month prior to hospitalization.
• Implementation of a TIPS in the month prior to admission.
• Presence of hepatocellular carcinoma with an expected survival < 3 months or any other progressive cancer.
• Adult person subject to legal protection (safeguard of justice, curatorship, guardianship), person deprived of liberty.